Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Island Pharmaceuticals Ltd ( (AU:ILA) ) is now available.
Island Pharmaceuticals Limited reported a significant decrease in income from ordinary activities, down 86% to $177,711, and an increased loss after tax of 36.9%, totaling $3,920,139 for the year ending June 30, 2025. The company did not declare any dividends during this period. Despite the financial setbacks, the net tangible assets per ordinary security improved from 1.20 cents to 3.03 cents, indicating a potential strengthening of the company’s asset base.
More about Island Pharmaceuticals Ltd
Island Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development and commercialization of drugs. The company’s primary products or services include pharmaceutical research and development, with a market focus on creating innovative treatments.
Average Trading Volume: 650,368
Technical Sentiment Signal: Buy
Current Market Cap: A$52.97M
For an in-depth examination of ILA stock, go to TipRanks’ Overview page.